35945502|t|Spatiotemporal evolution of pyroptosis and canonical inflammasome pathway in hSOD1G93A ALS mouse model.
35945502|a|BACKGROUND: Evidences indicate that inflammasome compounds participate in amyotrophic lateral sclerosis (ALS), a fatal progressive motoneuron degenerative disease. Researchers have observed the expressions of nucleotide oligomerization domain (NOD)-like receptor protein 3 (NLRP3) related inflammasome components in specific regions of the central nervous system in different ALS models, but the cellular spatiotemporal evolution of this canonical inflammasome pathway and pyroptosis during ALS progression are unclear. METHODS: The spinal cords of hSOD1G93A mice (ALS mice) and age-matched littermates (CON mice) were dissected at pre-symptomatic stage (60 d), early- symptomatic stage (95 d), symptomatic stage (108 d) and late-symptomatic stage (122 d) of the disease. By using Nissl staining, double immunofluorescence labelling, qRT-PCR or western blot, we detected morphology change and the expression, cellular location of GSDMD, NLRP3, caspase-1 and IL-1beta in the ventral horn of lumbar spinal cords over the course of disease. RESULTS: Neural morphology changes and GSDMD+/NeuN+ double positive cells were observed in ventral horn from ALS mice even at 60 d of age, even though there were no changes of GSDMD mRNA and protein expressions at this stage compared with CON mice. With disease progression, compared with age-matched CON mice, increased expressions of GSDMD, NLRP3, activated caspase-1 and IL-1beta were detected. Double immunofluorescence labeling revealed that NLRP3, caspase-1, IL-1beta positive signals mainly localized in ventral horn neurons at pre- and early-symptomatic stages. From symptomatic stage to late-symptomatic stage, robust positive signals were co-expressed in reactive astrocytes and microglia. CONCLUSIONS: Early activation of the canonical NLRP3 inflammasome induced pyroptosis in ventral horn neurons, which may participate in motor neuron degeneration and initiate neuroinflammatory processes during ALS progression.
35945502	87	90	ALS	Disease	MESH:D000690
35945502	91	96	mouse	Species	10090
35945502	178	207	amyotrophic lateral sclerosis	Disease	MESH:D000690
35945502	209	212	ALS	Disease	MESH:D000690
35945502	235	266	motoneuron degenerative disease	Disease	MESH:D019636
35945502	378	383	NLRP3	Gene	216799
35945502	480	483	ALS	Disease	MESH:D000690
35945502	595	598	ALS	Disease	MESH:D000690
35945502	663	667	mice	Species	10090
35945502	669	672	ALS	Disease	MESH:D000690
35945502	673	677	mice	Species	10090
35945502	712	716	mice	Species	10090
35945502	1034	1039	GSDMD	Gene	69146
35945502	1041	1046	NLRP3	Gene	216799
35945502	1048	1057	caspase-1	Gene	12362
35945502	1062	1070	IL-1beta	Gene	16176
35945502	1181	1186	GSDMD	Gene	69146
35945502	1188	1192	NeuN	Gene	52897
35945502	1251	1254	ALS	Disease	MESH:D000690
35945502	1255	1259	mice	Species	10090
35945502	1318	1323	GSDMD	Gene	69146
35945502	1385	1389	mice	Species	10090
35945502	1447	1451	mice	Species	10090
35945502	1478	1483	GSDMD	Gene	69146
35945502	1485	1490	NLRP3	Gene	216799
35945502	1502	1511	caspase-1	Gene	12362
35945502	1516	1524	IL-1beta	Gene	16176
35945502	1589	1594	NLRP3	Gene	216799
35945502	1596	1605	caspase-1	Gene	12362
35945502	1607	1615	IL-1beta	Gene	16176
35945502	1889	1894	NLRP3	Gene	216799
35945502	1977	2002	motor neuron degeneration	Disease	MESH:D009410
35945502	2016	2033	neuroinflammatory	Disease	MESH:D000090862
35945502	2051	2054	ALS	Disease	MESH:D000690
35945502	Association	MESH:D009410	216799
35945502	Association	MESH:D000690	216799
35945502	Association	MESH:D000690	69146
35945502	Association	MESH:D000090862	216799

